CN1114201A - Medicine for removing tumour and preparing process thereof - Google Patents
Medicine for removing tumour and preparing process thereof Download PDFInfo
- Publication number
- CN1114201A CN1114201A CN95110222A CN95110222A CN1114201A CN 1114201 A CN1114201 A CN 1114201A CN 95110222 A CN95110222 A CN 95110222A CN 95110222 A CN95110222 A CN 95110222A CN 1114201 A CN1114201 A CN 1114201A
- Authority
- CN
- China
- Prior art keywords
- temperature
- mirabilitum
- alumen
- medicine
- stone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 9
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 6
- 229940079593 drug Drugs 0.000 title 1
- 238000001354 calcination Methods 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 30
- 239000004575 stone Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000003837 high-temperature calcination Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 239000000571 coke Substances 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 2
- 238000002156 mixing Methods 0.000 abstract description 11
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- -1 alum Chemical compound 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 abstract 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 239000010446 mirabilite Substances 0.000 abstract 1
- 201000002528 pancreatic cancer Diseases 0.000 abstract 1
- 208000008443 pancreatic carcinoma Diseases 0.000 abstract 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 abstract 1
- 239000002574 poison Substances 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 201000009030 Carcinoma Diseases 0.000 description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 241000219112 Cucumis Species 0.000 description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 4
- 241000276427 Poecilia reticulata Species 0.000 description 4
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 4
- 244000153234 Hibiscus abelmoschus Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The medicine for curing cancer of liver, pancreatic cancer, other cancers and cancer transfer with high curative effect and cure rate is made up of nitre, alum, Glauber's salt, oyster shell, edible salt, bluestone, etc. through breaking, proportioning, high-temp. calcining cold storage, grinding and mixing.
Description
The present invention relates to a kind of medicine, particularly treat the medicine of carcinoma.
Carcinoma is the commonly encountered diseases of a kind of serious harm human health and life, however the up to the present international and domestic specific medicament that does not still have this disease of radical cure.
The purpose of this invention is to provide a kind of cure rate height, the treatment carcinoma medicine of instant effect.
The object of the present invention is achieved like this:
1, composition (weight portion)
Sal Nitri 30-50, Bai Shi 10-40, Alumen 30-80, Mirabilitum 10-30, Concha Ostreae 40-100 is total to stone 10-50, Moschus 5-10.
2, preparation technology
(1), weighing and burden, above-mentioned raw materials composition pulverize separately is become the end;
(2), high-temperature calcination, with the Sal Nitri in the above-mentioned powder, Alumen, the Mirabilitum powder mixes evenly after, put into hermetic container, placed 500-850 ℃ of temperature lower calcination 20-30 minute.
(3), cold preservation grinds, the mixture after calcining is natural cooling at room temperature, places under the 2-4 ℃ of temperature cold preservation 20-30 hour, is ground into powder then and by 100 eye mesh screens.
(4), mixed-forming, calcining mixt with by the white stone of said ratio weighing, Concha Ostreae, stone, Moschus mix altogether, can be processed into ball as required, loose, fry in shallow oil decoction, electuary, capsule, tablet.
The present invention adopts Chinese medical discrimination to cure Design Theory, and it is sensible to open meridians, treats consumptive lung disease, controls malignant boil, the therapeutic method to keep the adverse QI flowing downwards, diuresis is washed away and is gathered cold and heat in the stomach, and malicious heresy is excreted, and eliminates carcinoma, can treat hepatocarcinoma effectively, cancer of pancreas, pulmonary carcinoma and carcinoma or carcinoma postoperative bone shift, and vertigo such as moves at disease.
Details of the present invention is provided by following examples.
Embodiment 1
1, get raw material Sal Nitri, Alumen, Mirabilitum, Concha Ostreae, stone, Sal, Melanteritum are pulverized altogether.
2, will carry out Weighing by following prescription through the raw material of pulverizing.
Sal Nitri 40g, Bai Shi 15g, Alumen 60g, Mirabilitum 20g, Concha Ostreae, 70g, common stone 20g, Moschus 5g, Sal 25g, Melanteritum 20g.
3, incite somebody to action Sal Nitri 40g, Alumen 60g, the Mirabilitum 20g mix homogeneously of weighing, put into the bique crucible and sealed with yellow mud 100g, Sal 25g, Melanteritum 20g.Be heated to 500 ℃-700 ℃ at high temperature (coke fire or carbon fire), calcined 20-30 minute.
4, the mixture after the calcining is after at room temperature natural cooling 20-30 hour, and it is Powdered to place mortar to be ground into, and by 100 eye mesh screens.
Embodiment 2:
Expectorant knot poison stagnates type except that comprising embodiment 1 mixture that obtains, and also need half time 25g, GUPI (sci) 75g, Poria 50g, two skin 25g, Pericarpium Citri Reticulatae 25g, Cinnabaris 0.5g grind up are with the embodiment 1 mixture uniform mixing that obtains.
Embodiment 3
Expectorant poison stasis of blood junction type is except that comprising embodiment 1 mixture that obtains, and also need half time 25g, Poria 50g, two skin 15g, Cortex Moutan 25g, Pericarpium Citri Reticulatae 25g, Cinnabaris 0.5g grind up are with the embodiment 1 mixture uniform mixing that obtains.
Embodiment 4
The stagnation of liver-QI poison stagnates type except that comprising embodiment 1 mixture that obtains, and also needs rhizoma sparganic 15g, Rhizoma Corydalis 15g, other first 15g, Radix Angelicae Sinensis 15g, Semen Pharbitidis 15g, Concha Ostreae 15g, Pericarpium Citri Reticulatae 15g grind up, with the embodiment 1 mixture uniform mixing that obtains.
Embodiment 5
Stagnation of QI sucutaneous nodule type also needs GUPI (sci) 65g, Pericarpium Citri Reticulatae 25g, half time 25g, grass to kowtow 15g, Endothelium corneum 15g, sub-skin 25g grind up, with the embodiment 1 mixture uniform mixing that obtains except that comprising embodiment 1 mixture that obtains.
Embodiment 6
The sucutaneous nodule poison stagnates type except that comprising embodiment 1 mixture that obtains, and also needs Rhizoma Curcumae 25g, seven melon 25g, Pericarpium Citri Reticulatae 25g, Poria 25g, GUPI (sci) 25g, sub-skin 25g grind up, with the embodiment 1 mixture uniform mixing that obtains.
Embodiment 7
The evil stasis of blood junction type of poison also needs half time 25g, Bin watchman's wooden clapper 15g, Rhizoma Atractylodis 15g, Cortex Phellodendri 15g, Myrrha 15g, the yellow 25g grind up of fore-telling, with the embodiment 1 mixture uniform mixing that obtains except that comprising embodiment 1 mixture that obtains.
Embodiment 8
Expectorant knot accumulation type also needs seven melon 15g, Olibanum 15g, two skin 15g, Poria 15g, GUPI (sci) 15g grind up, with the embodiment 1 mixture uniform mixing that obtains except that comprising embodiment 1 mixture that obtains.
Embodiment 9
Pent-up expectorant poison type also needs seven melon 15g, Pericarpium Citri Reticulatae Viride 15g, Pericarpium Citri Reticulatae 15g, Radix Angelicae Dahuricae 15g, male hole 25g, Spica Prunellae 20g grind up, with the embodiment 1 mixture uniform mixing that obtains except that comprising embodiment 1 mixture that obtains.
Embodiment 10
Expectorant poison junction type also needs Poria 15g, seven melon 15g, Pericarpium Citri Reticulatae 15g, foretells yellow 15g, male hole 15g except that comprising embodiment 1 mixture that obtains, with the embodiment 1 mixture uniform mixing that obtains.
Embodiment 11
The sucutaneous nodule interlocking type also needs Spica Prunellae 20g, Thallus Laminariae (Thallus Eckloniae) 20g, Concha Ostreae 20g, two skin 15g, Radix Angelicae Dahuricae 20g grind up, with the embodiment 1 mixture uniform mixing that obtains except that comprising embodiment 1 mixture that obtains.
Claims (3)
1, a kind of medicine for removing tumour is characterized in that: its composition is: (weight portion)
Sal Nitri 30-50, Bai Shi 10-40, Alumen 30-80, Mirabilitum 10-30, Concha Ostreae 40-100 is total to stone 10-50, Moschus 5-10.
2, the technology of the described medicine for removing tumour of assaulting fortified position of preparation claim 1, it is characterized in that: the described various compositions of claim 1 are ground into the end, with Sal Nitri wherein, Alumen, after the Mirabilitum powder mixes is even, put into hermetic container, placed under the 500-850 ℃ of temperature high-temperature calcination 20-30 minute, mixture after calcining is at room temperature behind the natural cooling, placed under the 2-4 ℃ of temperature cold preservation 20-30 hour, be ground into powder then and by 100 eye mesh screens, at last with calcining mixt and white stone by the said ratio weighing, Concha Ostreae, be total to stone, the Moschus powder mixes, and can be processed into ball as required, loose, fry in shallow oil decoction, electuary, capsule, tablet.
3, preparation technology according to claim 2, it is characterized in that: high-temperature calcination is with Sal Nitri as claimed in claim 1, Alumen, Mirabilitum mix homogeneously, putting into the bique crucible is sealed for 20 parts with 100 parts of yellow mud, 25 parts of Sal, Melanteritum, be heated to 500 ℃-700 ℃ at high temperature (coke fire or carbon fire), calcined 20-30 minute.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95110222A CN1063328C (en) | 1995-05-10 | 1995-05-10 | Medicine for removing tumour and preparing process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95110222A CN1063328C (en) | 1995-05-10 | 1995-05-10 | Medicine for removing tumour and preparing process thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1114201A true CN1114201A (en) | 1996-01-03 |
CN1063328C CN1063328C (en) | 2001-03-21 |
Family
ID=5077629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95110222A Expired - Fee Related CN1063328C (en) | 1995-05-10 | 1995-05-10 | Medicine for removing tumour and preparing process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1063328C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058601C (en) * | 1996-11-04 | 2000-11-22 | 张士义 | Chinese medicinal herbs pesticide and preparation process |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920002227B1 (en) * | 1988-05-13 | 1992-03-20 | 야기 안테나 가부시끼가이샤 | Micro-strip array antenna |
CN1100944A (en) * | 1993-12-31 | 1995-04-05 | 张校苏 | Prepared Chinese medicine for curing tumor of digestive canal system |
-
1995
- 1995-05-10 CN CN95110222A patent/CN1063328C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058601C (en) * | 1996-11-04 | 2000-11-22 | 张士义 | Chinese medicinal herbs pesticide and preparation process |
Also Published As
Publication number | Publication date |
---|---|
CN1063328C (en) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102283867B (en) | Traditional Chinese medicine composition for treating cancer | |
CN1290550C (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
CN101062296A (en) | Chinese-medicinal capsule for treating facial spasm and its preparing process | |
CN1895555A (en) | Bone-connecting pill and its preparation | |
CN1063328C (en) | Medicine for removing tumour and preparing process thereof | |
CN102068653A (en) | Medicament for preparing Tibetan medicament preparation for treating liver diseases | |
CN107115493A (en) | It is a kind of to treat Chinese medicine composition of fracture and its production and use | |
CN108126024A (en) | A kind of pharmaceutical composition for treating rheumatoid arthritis | |
CN101347582A (en) | Chinese medicinal composition for dispelling wind and freeing collateral vessels, strengthening muscles and bones, and preparation method thereof | |
CN1739776A (en) | Chinese herbal medicine decoction for treating senile dementia caused by marrow sea deficiency | |
CN1217204A (en) | Medicine for nourishing muscle and recovering physical strength, and preparation method therefor | |
CN108175841A (en) | Chinese medicine preparation of gastritis, gastric ulcer and preparation method thereof to the ill | |
CN101780188B (en) | Capsule for treating prostatic diseases | |
CN106421553A (en) | Paclitaxel detoxified compound extract with anti-cancer effect and method for preparing paclitaxel detoxified compound extract | |
CN110946941A (en) | Traditional Chinese medicine for treating tumor | |
CN1044327C (en) | Traditional Chinese proprietary medicine for curing enterogastric disease | |
CN1081044C (en) | Prescription, preparation of medicine for treating cancer and its instructions of taking medicine | |
CN1739663A (en) | Application of ciliate bugle herb piece in preparing medicine for treating scapulohumeral periarthritis | |
CN1060214A (en) | The preparation method of kidney and relieve asthma Chinese medicine patent medicine | |
CN105031587A (en) | Chinese herba preparation for curing gastrointestinal diseases | |
CN1050998C (en) | Pill for treatment of diabetes mellitus and nephritis, and preparing process thereof | |
CN1072945C (en) | Medicine for curing psychosis and preparation process thereof | |
CN101138588B (en) | Pharmaceutical composition for treating gland hyperplasia and method of preparing the same | |
CN104306719A (en) | Traditional Chinese medicine combination for curing stomach cancer, and preparation method and application thereof | |
CN1751695A (en) | Traditional Chinese medicine for treating bone injury |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |